Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07310927
PHASE2/PHASE3

Alginate vs Sucralfate for GERD Symptomatic Relief

Sponsor: CMH Lahore Medical College and Institute of Dentistry

View on ClinicalTrials.gov

Summary

Gastroesophageal reflux disease (GERD) is a chronic gastrointestinal disorder characterized by the regurgitation of gastric contents into the esophagus.It can also present in an atypical manner such as chest pain, dental erosions, chronic cough, laryngitis, or asthma i.e. extra gastroesophageal symptoms. Sucralfate is a unique anti-ulcer drug and is a basic aluminum salt of sucrose octa-sulfate. It forms a protective layer, enhancing bicarbonate production, demonstrating anti-peptic properties, and fostering tissue growth, regeneration, and repair and it undergoes minimal enteral reabsorption. Alginate is a naturally occurring anionic polymer typically obtained from brown seaweed and has been extensively investigated and used for many biomedical applications, due to its biocompatibility, low toxicity, relatively low cost, and mild gelation by addition of divalent cations such as Ca2+.Both sucralfate and alginate have been in use for the treatment and symptomatic relief of GERD and are well tolerated oral formulations.

Official title: Alginate vs Sucralfate for GERD Symptomatic Relief in Combination With PPIS

Key Details

Gender

All

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

140

Start Date

2025-04-01

Completion Date

2026-04

Last Updated

2026-03-19

Healthy Volunteers

No

Conditions

Interventions

DRUG

Alginate

2 Table spoon spoon suspension syrup twice a day before meal.

DRUG

Sucralfate

2 Table spoon spoon suspension syrup twice a day before meal.

Locations (1)

Cmh Lahore

Lahore, Punjab Province, Pakistan